Silence Therapeutics plc (NASDAQ:SLN) Q4 2024 Earnings Call Transcript

Silence Therapeutics plc (NASDAQ:SLN) Q4 2024 Earnings Call Transcript February 28, 2025

Gem Hopkins: Good morning and good afternoon, everyone. Thank you for joining us today. My name is Gem Hopkins, Vice President of Investor Relations and Corporate Communications at Silence. Joining me on today’s call are Craig Tooman, our President and CEO, who will provide an update on the business; Rhonda Hellums, our Chief Financial Officer, who will review our financial performance; and Steven...